Page last updated: 2024-08-24

imiquimod and Carcinoma, Epidermoid

imiquimod has been researched along with Carcinoma, Epidermoid in 164 studies

Research

Studies (164)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's75 (45.73)29.6817
2010's64 (39.02)24.3611
2020's25 (15.24)2.80

Authors

AuthorsStudies
Jonnalagadda, S; Palle, K; Reedy, M1
Ahmed, I; Bowden, SJ; Gaunt, C; Gaunt, P; Green, AC; Harwood, CA; Hasan, ZU; Hogan, S; Homer, V; Ismail, F; Jefferson-Hulme, Y; Kentley, J; Lear, JT; Matin, RN; Milligan, A; Mitchell-Worsford, L; Proby, CM; Thomson, J; Van-de-Velde, V; Wheatley, K; Whitmarsh, T1
Ahmady, S; Arits, AHMM; de Rooij, MJM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF1
Cheng, B; Etzkorn, JR; Giordano, CN; Higgins, HW; Miller, CJ; Shin, TM; Sobanko, JF; Veerabagu, S1
Borroni, RG; Bressan, A; Cortese, A; Costanzo, A; Fiorillo, G; Toso, F; Tronconi, MC1
Algarin, YA; Jambusaria-Pahlajani, A; Patel, VA; Ruiz, E1
Arthur, A; Badiavas, E; Kirsner, R; Nahm, W; Nichols, A; Rapoport, E; Shen, J; Wyant, W1
Cornacchia, L; Lai, M; Longo, C; Pampena, R; Pellacani, G; Peris, K1
Dirschka, T; Gollnick, H; Kerl, H; Kunstfeld, R; Ostendorf, R1
Collins, A; Doerfler, L; Savas, J1
Arimura, A; Kanekura, T; Kirishima, M; Tanimoto, A1
Marchetti, MA; Marghoob, AA; Navarrete-Dechent, C1
Linares-Gonzalez, L; Navarro-Triviño, FJ; Ródenas-Herranz, T; Ruiz-Villaverde, R1
Conforti, C; Corneli, P; di Meo, N; Dianzani, C; Farinazzo, E; Giuffrida, R; Magaton Rizzi, G; Moret, A; Zalaudek, I1
Corbeddu, M; Ferreli, C; Fumo, G; Robustelli Test, E; Rongioletti, F1
Fayne, R; Nanda, S; Nichols, A; Shen, J1
Brogden, DRL; Kontovounisios, C; Mills, SC; Pellino, G; Tekkis, P; Walsh, U1
Aydin, AM; Chahoud, J; Cheryian, SK; Hajiran, A; Pow-Sang, JM; Spiess, PE; Zemp, L1
Benedetto, C; Bertero, L; Bevilacqua, F; Borella, F; Carosso, AR; Cassoni, P; Castellano, I; Collemi, G; Cosma, S; Gallio, N; Micheletti, L; Preti, M1
Feldman, SR; Heron, CE1
Badiavas, EV; Gonzalez, AM; Kirsner, RS; Moore, K; Nagrani, N; Nahm, WJ; Nichols, AJ; Shen, J; Zito, PM1
Fontenete, S; Haedersdal, M; Lerche, CM; Olesen, UH; Paasch, U; Perez-Moreno, M1
Kerner, JD; Kerner, JV; Ondo, AL; Ondo, IP; Shanler, SD; Trainor, P1
Giacomantonio, CA; Helyer, LK; Pasternak, S; Peltekian, K; Simms, GA; Stein, J; Vidovic, D; Walsh, M1
Bennardo, L; Cisale, GY; Nisticò, SP; Pentangelo, G; Provenzano, E1
Bennardo, F; Bennardo, L; Dastoli, S; Giudice, A; Morrone, P; Nisticò, SP; Passante, M; Patruno, C; Provenzano, E1
Brewer, JD; Lang, ME; Stewart, JR1
Arron, ST; Caputo, M; Charruyer, A; Fong, S; Foster, RD; Ghadially, R; Horton, KM; North, JP; Sano, S; Sklar, S; Soeung, C; Tabernik, L; Taneja, M; Uchida, Y; Vitcov, GG; Yue, L1
Shi, L; Wang, P; Wang, X; Zhang, G; Zhang, H; Zhang, L; Zhao, Z; Zhou, Z1
Chen, WR; Luo, M; Shi, L; Wang, B; Wang, P; Wang, X; Yang, D; Zhang, F; Zhang, G; Zhang, H; Zhang, L; Zhang, Y; Zhou, F1
Que, SKT; Schmults, CD; Zwald, FO1
Baraldi, C; Dika, E; Fanti, PA; Guglielmo, A; Lambertini, M; Patrizi, A; Ravaioli, GM; Scarfì, F; Veronesi, G1
Bhatta, AK; Ji, J; Keyal, U; Wang, P; Wang, X; Zhang, G; Zhao, Z; Zhu, L1
Guevara-Gutiérrez, E; Hernández-Torres, M; Ledesma, GS; Ruiz-González, JF; Tlacuilo-Parra, A1
Corbett, A; Kermode, AG; Reddel, SW; Triplett, J1
Asgari, MM; Chren, MM; Friedman, GD; Neugebauer, R; Sokil, M; Su, KA; Zhu, Z1
Gupta, P; Kakkar, N; Singh, H; Singh, M; Zadeng, Z1
Bianchi, L; Caposiena Caro, RD; Di Prete, M; Didona, D; Orlandi, A; Sechi, A1
Council, ML; Nemer, KM1
Chitwood, K; Cohen, G; Etzkorn, J1
Dosekun, O; Farrugia, P; Lewis, F; Sethi, G1
Calzavara Pinton, P; Catricalà, C; Neri, L; Pellacani, G; Peris, K; Peserico, A; Pimpinelli, N2
Bierhoff, E; Dirschka, T; Schmitz, L1
Bejarano, PA; Berho, M; Boutros, M1
Dhote, V; Gupta, V; Paul, BN; Trivedi, P1
Chang, IK; Choi, DK; Hur, GM; Im, M; Kim, CD; Lee, JH; Lee, Y; Li, ZJ; Lim, JW; Seo, YJ; Sohn, KC; Zhang, T1
Bontumasi, NM; Hurst, EA; Sheinbein, D1
Philipp-Dormston, WG1
Chen, YJ; Chen, YY; Huang, SW; Kao, JK; Liang, SM; Shieh, JJ; Wang, ST; Wu, CY1
Egekvist, H; Erlendsson, AM; Haedersdal, M; Lorentzen, HF; Philipsen, PA; Stausbøl-Grøn, B; Stender, IM1
Baraldi, C; Dika, E; Fanti, PA; Patrizi, A; Venturi, M1
Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K1
Mohd Amin, MC; Rehman, K; Yuen, NP; Zulfakar, MH1
Caglia, M; Hashemi, P; Kim, C; Shulman, K1
Bartha, Á; Dirschka, T; Schmitz, L1
Araki, Y; Arima, M; Iwata, Y; Kobayashi, T; Matsunaga, K; Numata, S; Okamura, K; Sugiura, K; Suzuki, T; Yagami, A1
Aneiros-Fernandez, J; Blasco-Morente, G; Martinez-Lopez, A; Naranjo-Diaz, MJ; Perez-Lopez, I; Ruiz-Villaverde, R; Tercedor-Sanchez, J1
Camacho-Martinez, F; Fernández-Crehuet, P; Pérez-Gil, A; Rios-Martin, JJ; Ruiz-Villaverde, R1
Neuhaus, I; North, J; Valdebran, M1
Brodland, DG; Murphy, ME; Zitelli, JA1
Chimenti, S; Saraceno, R; Teoli, M1
Clark, RA; Edwards, V; Hijnen, D; Huang, SJ; Kim, JE; Kupper, TS; Lambert, J; Miller, DM; Mollet, IG; Murphy, GF; Muthukuru, M; Schanbacher, CF1
French, LE; Hofbauer, GF; Koch, S; Läuchli, S; Pini, AM; Schärer, L1
Arechavala, RS; García-Río, I; González, LC; González-Pérez, R; Michelena, IA; Murua, AA; Santarén, BC; Urra, IT1
Baer, KE; Bergman, PJ; Craft, D; Gill, VL; Leung, C1
Stockfleth, E1
Ulrich, C1
Calarese, AW; Clark, RA; Hijnen, D; Huang, SJ; Kupper, TS; Miller, DM; Mollet, IG; Murphy, GF; Schanbacher, CF; Schmults, CD1
Coldiron, BM; Rogers, HW1
Bernhard, JD; Bordeaux, JS; Love, WE1
Baek, GH; Cho, JH; Chung, MS; Gong, HS; Roh, YH1
Collins, C; Harrad, RA; Kennedy, CT; Ross, AH1
Cordoro, KM; Greer, KE; Lonergan, CL; McNamara, EK1
Muhn, C; Rosen, N; Shoimer, I1
Adam, F; Fenske, NA; Spencer, J1
Kerl, H; Kopera, D1
Chrisovergis, A; Eleftheriadou, A; Ferekidou, E; Gkoulioni, V; Kandiloros, D; Lazaris, ACh; Yiotakis, I1
Braga, JC; Busam, K; Dusza, SW; Gill, M; Halpern, AC; Marghoob, AA; Scope, A; Terushkin, V1
Barton, SE; Bower, M; Dixon, G; Fox, PA; Francis, N; Nathan, M; Singh, N; Weir, J1
Doherty, SD; Rosen, T; Shah, AY1
Aaronson, NK; Blok, LJ; Ewing, PC; Gundy, CM; Heijmans-Antonissen, C; Helmerhorst, TJ; Quint, WG; Terlou, A; van Beurden, M; van Seters, M1
Delaney, T; Foxton, G1
Frankel, A; Goldenberg, G1
Anolik, R; Brightman, L; Geronemus, R; Warycha, M1
Barysch, MJ; Dummer, R; Kamarashev, J; Lockwood, LL1
McLaughlin, PJ; Stucki, JK; Zagon, IS1
Chu, J; Hartman, R; Meehan, S; Patel, R; Stein, JA1
El Tal, AK; MacFarlane, DF1
Fotiadou, C; Giannopoulou, C; Ioannides, D; Lazaridou, E1
Jadotte, YT; Schwartz, RA1
Attili, SK; Fleming, C; Ibbotson, SH1
Digiovanni, J; Kamijima, R; Nakajima, K; Sano, S; Takaishi, M; Yokogawa, M1
Ahn, MY; Ahn, SG; Cheong, HH; Kwon, SM; Lee, J; Min, SK; Park, JH; Yoon, JH1
He, Q; Introcaso, CE; Kovarik, CL; Rady, PL; Tyring, SK1
Sullivan, TJ1
de C Monteiro, JS; de Oliveira, SC; de Souza, SC; dos Santos, JN; Gurgel, CA; Pinheiro, AL; Reis Júnior, JA1
Firnhaber, JM1
Cleaver, L; Knabel, P1
Guill, CK; Orengo, I; Rosen, T1
Hruza, G1
Barten, M; Gross, G; Gundlach, KK; Saka, B; Wenzel, K; Zimmermann, R1
Garland, SM1
Hamza, S; Skelton, H; Smith, KJ2
Campagne, G; Martínez, A; Roca, M1
Goldberg, LH; Peterson, SR1
Benninghoff, B; Bong, AB; Drewniok, C; Geilen, CC; Gollnick, H; Herz, J; Reifenberger, J; Schön, M; Schön, MP; Slade, HB1
Dorn, C; Kupka, M; Petrow, W; Richter, ON; Ulrich, U; Wardelmann, E1
Schmook, T; Stockfleth, E1
Beyeler, M; Burg, G; Dummer, R; Morcinek, J1
Del Rosso, JQ1
Chosidow, O; Dummer, R1
Danielsen, AG; Sand, C; Weismann, K1
Chen, K; Shumack, S1
Kossard, S1
Reifenberger, J; Schön, MP1
Alam, M; Goldberg, LH; Silapunt, S1
Oster-Schmidt, C1
Arlette, JP; Trotter, MJ1
Hengge, UR; Schaller, J2
Cruces, M; de la Torre, C; Feal, C; Flórez, A1
Ladd, DJ; Lin, R; Powell, DJ; Way, BV1
Huntley, A; Navi, D1
Dummer, R; Urosevic, M1
Armario-Hita, J; Fernández-Vozmediano, J1
Martín-García, RF1
Delli, F; Dionyssopoulos, A; Koussidou-Eremondi, T; Mandekou-Lefaki, I; Mourellou-Tsatsou, O1
Keller, CD1
Atkins, CL; Brown, VL; Cerio, R; Ghali, L; Harwood, CA; Proby, CM1
Higgins, SP; Poluri, RM1
Dirschka, T; Oster-Schmidt, C1
Altmeyer, P; Markus, S; Oster-Schmidt, C1
Haustein, UF; Paasch, U1
Ogawa, H; Palungwachira, P1
Derry, S; Hadley, G; Moore, RA1
Konstantopoulou, M; Lord, MG; Macfarlane, AW1
Berman, B; Bienstock, L; Kuritzky, L; Mayeaux, EJ; Tyring, SK1
Gibson, SJ; Inglefield, JR; Larson, CJ; Lebrec, H; Miller, RL1
Chimenti, S; Fargnoli, MC; Lozzi, GP; Micantonio, T; Peris, K1
Dissemond, J; Grabbe, S1
Adim, SB; Baskan, EB; Toker, S; Tunali, S; Turan, A1
Goh, MS1
Carrington, PR; D'Addario, S1
Mings, SM; Ondo, AL; Pestak, RM; Shanler, SD1
Berthelot, C; Dickerson, MC; He, Q; Niroomand, F; Pandya, AG; Rady, P; Tyring, SK1
Dixon, A1
Assimakopoulos, DA; Benton, J; Fika, Z; Karkos, PD1
Carroll, MT; Tillman, DK1
Bunker, CB; Singh, S1
Ferrándiz, C1
Amerio, P; Bichel, J; Euvrard, S; Guidi, B; Proby, CM; Rønnevig, J; Slade, HB; Stockfleth, E; Ulrich, C; van de Kerkhof, PC1
Krawtchenko, N; Mann, I; Roewert-Huber, J; Sterry, W; Stockfleth, E; Ulrich, M1
Bichel, J; Carey-Yard, M; Sterry, W; Stockfleth, E1
Miller, WH; Peters-Kennedy, J; Scott, DW1
Donahue, RN; McLaughlin, PJ; Rogosnitzky, M; Zagon, IS1
Warshauer, BL; Warshauer, E1
Cohen, GF; Taliaferro, SJ1
Pehoushek, J; Smith, KJ1
Hengge, UR; Stark, R1
Bieber, T; Gerdsen, R; Petrow, W; Richter, O; Uerlich, M1
Schroeder, TL; Sengelmann, RD1

Reviews

40 review(s) available for imiquimod and Carcinoma, Epidermoid

ArticleYear
Advances in Topical Treatments of Cutaneous Malignancies.
    American journal of clinical dermatology, 2023, Volume: 24, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Quality of Life; Skin Neoplasms

2023
Treatments of actinic cheilitis: A systematic review of the literature.
    Journal of the American Academy of Dermatology, 2020, Volume: 83, Issue:3

    Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Cheilitis; Combined Modality Therapy; Dermabrasion; Diclofenac; Disease Progression; Fluorouracil; Humans; Imiquimod; Laser Therapy; Lip Neoplasms; Photochemotherapy; Precancerous Conditions; Treatment Outcome

2020
Long-term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2020, Volume: 34, Issue:1

    Topics: Adjuvants, Immunologic; Aged; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Diclofenac; Facial Neoplasms; Female; Gels; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Scalp; Skin Cream

2020
Nonsurgical Treatments for Nonmelanoma Skin Cancer.
    Dermatologic clinics, 2019, Volume: 37, Issue:4

    Topics: Administration, Cutaneous; Anilides; Antineoplastic Agents; Antineoplastic Agents, Immunological; Biphenyl Compounds; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Programmed Cell Death 1 Receptor; Pyridines; Radiotherapy; Skin Neoplasms; Watchful Waiting

2019
Successful treatment of micaceous balanitis with 5% topical imiquimod: case report and review of the literature.
    International journal of dermatology, 2020, Volume: 59, Issue:6

    Topics: Administration, Topical; Adult; Balanitis; Carcinoma, Squamous Cell; Disease Progression; Humans; Imiquimod; Male; Penile Neoplasms; Precancerous Conditions; Treatment Outcome

2020
Current therapies for actinic keratosis.
    International journal of dermatology, 2020, Volume: 59, Issue:6

    Topics: Aftercare; Carcinoma, Squamous Cell; Chemexfoliation; Cryotherapy; Curettage; Dermoscopy; Diclofenac; Disease Progression; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy; Practice Guidelines as Topic; Protective Clothing; Skin; Skin Neoplasms; Sunlight; Sunscreening Agents

2020
Evaluating the efficacy of treatment options for anal intraepithelial neoplasia: a systematic review.
    International journal of colorectal disease, 2021, Volume: 36, Issue:2

    Topics: Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; HIV Infections; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections

2021
Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review.
    International journal of molecular sciences, 2020, Dec-27, Volume: 22, Issue:1

    Topics: Adjuvants, Immunologic; Alphapapillomavirus; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Neuroendocrine Tumors; Paget Disease, Extramammary; Prognosis; Vulvar Neoplasms

2020
Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Graft Rejection; Humans; Imiquimod; Immunocompromised Host; Immunosuppression Therapy; Infusions, Intralesional; Interleukin-2; Kidney Transplantation; Liver Transplantation; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Transplant Recipients; Treatment Outcome

2021
Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?
    Current oncology (Toronto, Ont.), 2021, 06-23, Volume: 28, Issue:4

    Topics: Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms

2021
Efficacy of nonexcisional treatment modalities for superficially invasive and in situ squamous cell carcinoma: A systematic review and meta-analysis.
    Journal of the American Academy of Dermatology, 2022, Volume: 87, Issue:1

    Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Skin Neoplasms

2022
Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
    Dermatologic clinics, 2019, Volume: 37, Issue:3

    Topics: Administration, Cutaneous; Administration, Oral; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemoprevention; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Niacinamide; Photochemotherapy; Retinoids; Skin Neoplasms

2019
Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:9

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bleomycin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Interferon alpha-2; Interferon-alpha; Keratoacanthoma; Methotrexate; Recombinant Proteins; Skin Neoplasms

2013
Anal squamous intraepithelial neoplasia.
    Gastroenterology clinics of North America, 2013, Volume: 42, Issue:4

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Photochemotherapy; Watchful Waiting

2013
Actinic keratoses.
    Cancer treatment and research, 2009, Volume: 146

    Topics: Aged; Aminoquinolines; Carcinoma, Squamous Cell; Cryotherapy; Dermatology; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Lasers; Medical Oncology; Models, Biological; Organ Transplantation; Photochemotherapy; Retinoids; Skin Neoplasms

2009
Topical treatment of field cancerization.
    Cancer treatment and research, 2009, Volume: 146

    Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis, Actinic; Organ Transplantation; Photochemotherapy; Recurrence; Skin Neoplasms; Tissue Distribution

2009
Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
    Archives of dermatology, 2009, Volume: 145, Issue:12

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Metabolic Clearance Rate; Skin Neoplasms

2009
Actinic keratoses: past, present and future.
    Journal of drugs in dermatology : JDD, 2010, Volume: 9, Issue:5 Suppl OD

    Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Cryosurgery; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Keratosis, Actinic; Photochemotherapy; Precancerous Conditions; Skin Neoplasms

2010
Actinic cheilitis: a treatment review.
    International journal of dermatology, 2010, Volume: 49, Issue:11

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Caustics; Cheilitis; Cryosurgery; Electrocoagulation; Fluorouracil; Humans; Imiquimod; Laser Therapy; Lip; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms; Trichloroacetic Acid

2010
Do lasers or topicals really work for nonmelanoma skin cancers?
    Seminars in cutaneous medicine and surgery, 2011, Volume: 30, Issue:1

    Topics: Administration, Cutaneous; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemexfoliation; Dermatologic Agents; Fluorouracil; Humans; Imiquimod; Laser Therapy; Nicotinic Acids; Paget Disease, Extramammary; Photochemotherapy; Skin Neoplasms

2011
Extramammary Paget disease.
    Dermatology online journal, 2011, Oct-15, Volume: 17, Issue:10

    Topics: Aminoquinolines; Antineoplastic Agents; Asian People; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Diagnostic Errors; Eczema; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Penile Neoplasms; Scrotum; Skin Neoplasms

2011
Role of non-surgical therapies in the management of periocular basal cell carcinoma and squamous intra-epidermal carcinoma: a case series and review of the literature.
    Photodermatology, photoimmunology & photomedicine, 2012, Volume: 28, Issue:2

    Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Eye; Female; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Skin Neoplasms

2012
Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens.
    Current opinion in ophthalmology, 2012, Volume: 23, Issue:5

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Fluorouracil; Humans; Imiquimod; Mitomycin; Orbital Neoplasms; Skin Neoplasms

2012
Diagnosis and treatment of Basal cell and squamous cell carcinoma.
    American family physician, 2012, Jul-15, Volume: 86, Issue:2

    Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryotherapy; Curettage; Dermatologic Surgical Procedures; Desiccation; Fluorouracil; Humans; Imiquimod; Mohs Surgery; Risk Factors; Skin; Skin Neoplasms

2012
Imiquimod.
    Current opinion in infectious diseases, 2003, Volume: 16, Issue:2

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers; Molluscum Contagiosum; Skin Neoplasms

2003
The imidazoquinolines and their place in the therapy of cutaneous disease.
    Expert opinion on pharmacotherapy, 2003, Volume: 4, Issue:7

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Condylomata Acuminata; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms

2003
Bowenoid papulosis of the vulva-immunotherapeutical approach with topical imiquimod.
    Archives of gynecology and obstetrics, 2003, Volume: 268, Issue:4

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Diabetes Mellitus, Type 1; Female; Humans; Imiquimod; Immunotherapy; Papillomaviridae; Papillomavirus Infections; Vulvar Neoplasms

2003
Current treatment patterns in non-melanoma skin cancer across Europe.
    The Journal of dermatological treatment, 2003, Volume: 14 Suppl 3

    Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryotherapy; Dermatology; Europe; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Skin Neoplasms

2003
[Cutaneous neoplasms].
    Praxis, 2003, Sep-03, Volume: 92, Issue:36

    Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors

2003
New and emerging topical approaches for actinic keratoses.
    Cutis, 2003, Volume: 72, Issue:4

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Diclofenac; Humans; Imiquimod; Keratosis; Skin Neoplasms; Treatment Outcome; United States

2003
Imiquimod: mode of action and therapeutic potential.
    Acta dermato-venereologica. Supplementum, 2003, Issue:214

    Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Imiquimod; Immune System; Papillomaviridae; Papillomavirus Infections; Skin Diseases; Skin Neoplasms

2003
Topical and light-based treatments for actinic keratoses.
    Seminars in cutaneous medicine and surgery, 2003, Volume: 22, Issue:3

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclooxygenase Inhibitors; Diclofenac; Fluorouracil; Humans; Hyaluronic Acid; Imiquimod; Keratosis; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Precancerous Conditions; Retinoids; Skin Neoplasms; Vitamin A

2003
Squamous cell carcinoma in situ of the skin: history, presentation, biology and treatment.
    The Australasian journal of dermatology, 2004, Volume: 45, Issue:1

    Topics: Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Female; Humans; Imiquimod; Male; Papillomavirus Infections; Skin; Skin Neoplasms; Ultraviolet Rays

2004
Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
    Dermatology online journal, 2004, Jul-15, Volume: 10, Issue:1

    Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Clinical Trials as Topic; Condylomata Acuminata; Drug Screening Assays, Antitumor; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunity, Cellular; Immunologic Factors; Keratoacanthoma; Keratosis; Male; Melanoma; Multicenter Studies as Topic; Mycosis Fungoides; Ointments; Paget Disease, Extramammary; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms

2004
Role of imiquimod in skin cancer treatment.
    American journal of clinical dermatology, 2004, Volume: 5, Issue:6

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Imiquimod; Immunologic Factors; Melanoma; Skin Neoplasms

2004
[Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2003, Volume: 1, Issue:10

    Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Middle Aged; Ointments; Precancerous Conditions; Prospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome; Ultraviolet Rays

2003
Imiquimod for actinic keratosis: systematic review and meta-analysis.
    The Journal of investigative dermatology, 2006, Volume: 126, Issue:6

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratosis; Ointments; Randomized Controlled Trials as Topic; Skin Neoplasms

2006
Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel.
    The Journal of family practice, 2006, Volume: 55, Issue:5

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Consensus Development Conferences as Topic; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photosensitivity Disorders; Practice Guidelines as Topic; Risk Factors; Skin Neoplasms; Ultraviolet Rays

2006
[Actinic keratosis].
    MMW Fortschritte der Medizin, 2006, Jun-15, Volume: 148, Issue:24

    Topics: Adjuvants, Immunologic; Age Factors; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Humans; Imiquimod; Interferon Inducers; Keratosis; Laser Therapy; Male; Ointments; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms; Time Factors; Ultraviolet Rays

2006
Update on actinic keratosis in clinical trial experience with imiquimod.
    The British journal of dermatology, 2007, Volume: 157 Suppl 2

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratosis; Neoplasms, Radiation-Induced; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays

2007

Trials

9 trial(s) available for imiquimod and Carcinoma, Epidermoid

ArticleYear
Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
    The British journal of dermatology, 2022, Volume: 187, Issue:3

    Topics: Carcinoma, Squamous Cell; Feasibility Studies; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Organ Transplantation; Sunscreening Agents; Transplant Recipients; Treatment Outcome

2022
Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.
    JAMA dermatology, 2022, 06-01, Volume: 158, Issue:6

    Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Skin Neoplasms; Treatment Outcome

2022
A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimod.
    AIDS (London, England), 2010, Sep-24, Volume: 24, Issue:15

    Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antiretroviral Therapy, Highly Active; Anus Neoplasms; Carcinoma, Squamous Cell; Double-Blind Method; HIV Infections; HIV-1; Homosexuality, Male; Humans; Imiquimod; Male

2010
Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial.
    Gynecologic oncology, 2011, Volume: 121, Issue:1

    Topics: Adult; Aminoquinolines; Antineoplastic Agents; Body Image; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Neoplasm Invasiveness; Quality of Life; Sexuality; Vulvar Neoplasms

2011
Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
    Archives of dermatology, 2005, Volume: 141, Issue:8

    Topics: Acitretin; Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind Method; Female; Humans; Imiquimod; Immunosuppression Therapy; Keratolytic Agents; Kidney Transplantation; Male; Middle Aged; Ointments; Precancerous Conditions; Risk Factors; Skin; Skin Neoplasms

2005
Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:2

    Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Bowen's Disease; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Male; Neoplasm Invasiveness; Skin Neoplasms; Treatment Outcome

2006
Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients.
    The British journal of dermatology, 2007, Volume: 157 Suppl 2

    Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imiquimod; Immunocompromised Host; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Organ Transplantation; Skin Neoplasms; Treatment Outcome

2007
A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
    The British journal of dermatology, 2007, Volume: 157 Suppl 2

    Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryosurgery; Esthetics; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Immunocompetence; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays

2007
Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
    The British journal of dermatology, 2007, Volume: 157 Suppl 2

    Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Facial Neoplasms; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Patient Compliance; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays

2007

Other Studies

115 other study(ies) available for imiquimod and Carcinoma, Epidermoid

ArticleYear
Case Report: Intra-Tumoral Vaccinations of Quadrivalent HPV-L1 Peptide Vaccine With Topical TLR-7 Agonist Following Recurrence: Complete Resolution of HPV-HR-Associated Gynecologic Squamous Cell Carcinomas in Two Patients.
    Pathology oncology research : POR, 2021, Volume: 27

    Topics: Adult; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections; Salvage Therapy; Toll-Like Receptor 7

2021
A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid.
    Journal of the American Academy of Dermatology, 2022, Volume: 87, Issue:3

    Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Retrospective Studies; Skin Neoplasms; Treatment Outcome

2022
Complete response of locally advanced cutaneous squamous cell carcinoma of the eyelid to topical imiquimod 3.75.
    Dermatologic therapy, 2022, Volume: 35, Issue:11

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Eyelids; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome

2022
Keratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin.
    Journal of drugs in dermatology : JDD, 2023, May-01, Volume: 22, Issue:5

    Topics: Carcinoma, Squamous Cell; Chemoprevention; Fluorouracil; Humans; Imiquimod; Keratinocytes; Keratosis, Actinic; Prospective Studies; Treatment Outcome; Tretinoin

2023
Eruptive squamous cell carcinoma in a patient treated with concomitant pembrolizumab and imiquimod.
    The Journal of dermatology, 2019, Volume: 46, Issue:12

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Lung Neoplasms; Neoplasms, Second Primary; Skin Neoplasms; Urinary Bladder Neoplasms

2019
Contemporary management of actinic keratosis.
    The Journal of dermatological treatment, 2021, Volume: 32, Issue:5

    Topics: Carcinoma, Squamous Cell; Cryotherapy; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms

2021
Efficacy of Imiquimod 3.75% for the treatment of extensive Bowen's disease of the face in an elderly patient.
    Dermatologic therapy, 2020, Volume: 33, Issue:2

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome

2020
Combination Topical Chemotherapy for the Treatment of an Invasive Cutaneous Squamous Cell Carcinoma
    Journal of drugs in dermatology : JDD, 2020, Feb-01, Volume: 19, Issue:2

    Topics: Administration, Cutaneous; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Diagnosis, Differential; Ear, External; Fluorouracil; Humans; Imiquimod; Male; Mohs Surgery; Skin Neoplasms

2020
Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity.
    Urologic oncology, 2021, Volume: 39, Issue:1

    Topics: Administration, Topical; Adult; Aged; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Cohort Studies; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Treatment Outcome

2021
Ingenol Mebutate and the Treatment of Actinic Keratosis.
    Journal of drugs in dermatology : JDD, 2021, 01-01, Volume: 20, Issue:1

    Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Clinical Trials as Topic; Diterpenes; Fluorouracil; Humans; Imiquimod; Incidence; Keratosis, Actinic; Patient Preference; Photochemotherapy; Photosensitizing Agents; Risk Assessment; Skin Neoplasms; Treatment Outcome

2021
A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers.
    Journal of drugs in dermatology : JDD, 2021, 03-01, Volume: 20, Issue:3

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cost-Benefit Analysis; Cryotherapy; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Tretinoin

2021
Tumor Clearance and Immune Cell Recruitment in UV-Induced Murine Squamous Cell Carcinoma Exposed to Ablative Fractional Laser and Imiquimod Treatment.
    Lasers in surgery and medicine, 2021, Volume: 53, Issue:9

    Topics: Animals; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Imiquimod; Lasers; Mice; Skin Neoplasms; Ultraviolet Rays

2021
Treatment of Cutaneous Squamous Cell Carcinoma In Situ With Curettage Followed by Topical Imiquimod 5% Cream.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2021, 05-01, Volume: 47, Issue:5

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Curettage; Female; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms; Surveys and Questionnaires

2021
Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip.
    Medicina (Kaunas, Lithuania), 2021, Jun-02, Volume: 57, Issue:6

    Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Humans; Imiquimod; Lip; Neoplasm Recurrence, Local; Papillomavirus Infections

2021
Brief Report: Interleukin-17A-Dependent Asymmetric Stem Cell Divisions Are Increased in Human Psoriasis: A Mechanism Underlying Benign Hyperproliferation.
    Stem cells (Dayton, Ohio), 2017, Volume: 35, Issue:8

    Topics: Aminoquinolines; Animals; Asymmetric Cell Division; Carcinoma, Squamous Cell; Cell Proliferation; Homeostasis; Humans; Imiquimod; Interleukin-17; Mice; Psoriasis

2017
Successful treatment of giant invasive cutaneous squamous cell carcinoma by plum-blossom needle assisted photodynamic therapy sequential with imiquimod: Case experience.
    Photodiagnosis and photodynamic therapy, 2018, Volume: 21

    Topics: Aged, 80 and over; Aminoquinolines; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Needles; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms

2018
Laser immunotherapy for cutaneous squamous cell carcinoma with optimal thermal effects to enhance tumour immunogenicity.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2018, Volume: 34, Issue:8

    Topics: Adjuvants, Immunologic; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Combined Modality Therapy; Female; HMGB1 Protein; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Imiquimod; Immunotherapy; Laser Therapy; Mice; Middle Aged; Phototherapy; Skin Neoplasms

2018
Reply to: "Cutaneous squamous cell carcinoma progression during imiquimod treatment".
    Journal of the American Academy of Dermatology, 2018, Volume: 79, Issue:1

    Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Squamous Cell; Disease Progression; Humans; Imiquimod; Skin Neoplasms

2018
Cutaneous squamous cell carcinoma progression during imiquimod treatment.
    Journal of the American Academy of Dermatology, 2018, Volume: 79, Issue:1

    Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Squamous Cell; Disease Progression; Humans; Imiquimod; Skin Neoplasms

2018
Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
    Photodiagnosis and photodynamic therapy, 2018, Volume: 23

    Topics: Aged; Aminolevulinic Acid; Animals; Apoptosis; Carcinoma, Squamous Cell; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Imiquimod; Inflammation Mediators; Male; Mice; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; T-Lymphocytes

2018
[Riesgo de recurrencia y de nuevas neoplasias cutáneas malignas en sujetos mexicanos con carcinoma basocelular].
    Cirugia y cirujanos, 2018, Volume: 86, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Electrocoagulation; Female; Humans; Imiquimod; Male; Margins of Excision; Middle Aged; Mohs Surgery; Neoplasms, Second Primary; Recurrence; Retrospective Studies; Risk; Skin Neoplasms; Young Adult

2018
Warts and all: Fingolimod and unusual HPV-associated lesions.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2019, Volume: 25, Issue:11

    Topics: Ankle; Antineoplastic Agents; Anus Neoplasms; Carcinoma, Squamous Cell; Cryotherapy; Fingers; Fingolimod Hydrochloride; Foot Dermatoses; Hand Dermatoses; Humans; Imiquimod; Immunosuppressive Agents; Lymphopenia; Multiple Sclerosis, Relapsing-Remitting; Papillomavirus Infections; Warts

2019
Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.
    Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4

    Topics: Administration, Cutaneous; Aged; California; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comparative Effectiveness Research; Female; Fluorouracil; Humans; Imiquimod; Intention to Treat Analysis; Keratinocytes; Keratosis, Actinic; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Risk Factors; Skin Neoplasms

2019
Treatment of squamous cell carcinoma of the eyelid with imiquimod 5% cream.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2019, Volume: 54, Issue:1

    Topics: Administration, Topical; Aged, 80 and over; Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Eyelid Neoplasms; Humans; Imiquimod; Magnetic Resonance Imaging; Male; Skin Cream

2019
Treatment of recalcitrant squamous carcinoma in situ of penis with tapering imiquimod 5-3.75% cream.
    Dermatologic therapy, 2019, Volume: 32, Issue:3

    Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Middle Aged; Ointments; Penile Neoplasms

2019
Vulval disease in HIV-positive women attending a tertiary vulval dermatology clinic over a five-year period.
    International journal of STD & AIDS, 2013, Volume: 24, Issue:10

    Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Imiquimod; Middle Aged; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vulvar Diseases

2013
Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2013, Volume: 148, Issue:5

    Topics: Aminoquinolines; Carcinoma, Squamous Cell; Case Management; Clinical Trials as Topic; Cryosurgery; Diagnosis, Differential; Diclofenac; Disease Management; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Italy; Keratosis, Actinic; Laser Therapy; Neoplasms, Radiation-Induced; Photochemotherapy; Practice Guidelines as Topic; Skin Neoplasms; Sunscreening Agents; United Kingdom; United States; Watchful Waiting

2013
Optical coherence tomography imaging of erythroplasia of Queyrat and treatment with imiquimod 5% cream: a case report.
    Dermatology (Basel, Switzerland), 2014, Volume: 228, Issue:1

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Erythroplasia; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Tomography, Optical Coherence

2014
Development of novel topical drug delivery system containing cisplatin and imiquimod for dual therapy in cutaneous epithelial malignancy.
    Journal of liposome research, 2014, Volume: 24, Issue:2

    Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Drug Delivery Systems; Humans; Imiquimod; Mice; Microscopy, Fluorescence; Rats, Wistar; Skin Neoplasms

2014
Imiquimod induces apoptosis of squamous cell carcinoma (SCC) cells via regulation of A20.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Aminoquinolines; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA-Binding Proteins; Humans; Imiquimod; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Nuclear Proteins; Toll-Like Receptor 7; Tumor Necrosis Factor alpha-Induced Protein 3

2014
Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2014, Volume: 149, Issue:2

    Topics: Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Attitude of Health Personnel; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryotherapy; Curettage; Dermatology; Dermoscopy; Diclofenac; Disease Management; Guideline Adherence; Humans; Imiquimod; Italy; Keratosis, Actinic; Laser Therapy; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Photochemotherapy; Photosensitivity Disorders; Physicians; Practice Guidelines as Topic; Practice Patterns, Physicians'; Skin Neoplasms; Sunlight; Surveys and Questionnaires

2014
Combination therapy for perianal squamous cell carcinoma in situ with imiquimod and photodynamic therapy.
    Cutis, 2014, Volume: 94, Issue:5

    Topics: Aminolevulinic Acid; Aminoquinolines; Anal Canal; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Dissection; Female; Humans; Imiquimod; Middle Aged; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Postoperative Complications; Skin Neoplasms; Treatment Outcome

2014
Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
    Current problems in dermatology, 2015, Volume: 46

    Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms

2015
Imiquimod-induced AMPK activation causes translation attenuation and apoptosis but not autophagy.
    Journal of dermatological science, 2015, Volume: 78, Issue:2

    Topics: Adenosine Triphosphate; Aminoquinolines; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Down-Regulation; Enzyme Activation; Gene Silencing; Humans; Imiquimod; Melanoma; Myeloid Cell Leukemia Sequence 1 Protein; Myeloid Differentiation Factor 88; Phosphorylation; Protein Biosynthesis; Protein Serine-Threonine Kinases; Signal Transduction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8

2015
Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
    International journal of dermatology, 2016, Volume: 55, Issue:3

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cross-Sectional Studies; Cryotherapy; Denmark; Dermatology; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Outpatient Clinics, Hospital; Photochemotherapy; Photosensitizing Agents; Practice Patterns, Physicians'; Private Practice; Sex Factors; Skin Neoplasms

2016
Non-melanoma skin cancer: to Mohs or not to Mohs?
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2015, Volume: 150, Issue:5

    Topics: Adult; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Follow-Up Studies; Humans; Imiquimod; Male; Microsurgery; Skin Neoplasms

2015
Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study.
    Journal of photochemistry and photobiology. B, Biology, 2016, Volume: 154

    Topics: Aminolevulinic Acid; Aminoquinolines; Animals; Calcitriol; Carcinoma, Squamous Cell; Female; Fluorouracil; Imiquimod; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Ultraviolet Rays

2016
Immunomodulatory Effectiveness of Fish Oil and omega-3 Fatty Acids in Human Non-melanoma Skin Carcinoma Cells.
    Journal of oleo science, 2016, Volume: 65, Issue:3

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Drug Combinations; Fatty Acids, Omega-3; Fish Oils; Humans; Imiquimod; Immunosuppressive Agents; Interleukin-10; Interleukin-6; Skin Neoplasms; Tumor Necrosis Factor-alpha

2016
Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate.
    Journal of drugs in dermatology : JDD, 2016, Volume: 15, Issue:3

    Topics: Acitretin; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Drug Resistance; Epidermodysplasia Verruciformis; Female; Gels; Humans; Imiquimod; Keratolytic Agents; Rare Diseases; Skin Neoplasms; Treatment Outcome; Tretinoin

2016
Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report.
    European journal of dermatology : EJD, 2016, Aug-01, Volume: 26, Issue:4

    Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Imiquimod; Male; Neoplasm Invasiveness; Scalp; Skin Neoplasms

2016
Case of Japanese Hermansky-Pudlak syndrome patient with deeply invasive squamous cell carcinoma and multiple lesions of actinic keratosis on the face and neck.
    The Journal of dermatology, 2017, Volume: 44, Issue:2

    Topics: Administration, Cutaneous; Adult; Carcinoma, Squamous Cell; Face; Hermanski-Pudlak Syndrome; Humans; Imiquimod; Japan; Keratosis, Actinic; Male; Membrane Proteins; Neck; Skin; Skin Neoplasms; Sunlight; Tomography, X-Ray Computed; Treatment Outcome

2017
Successful treatment of proliferative verrucous leukoplakia with 5% topical imiquimod.
    Dermatologic therapy, 2017, Volume: 30, Issue:2

    Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Carcinoma, Squamous Cell; Carcinoma, Verrucous; Female; Humans; Imiquimod; Leukoplakia, Oral; Treatment Outcome

2017
Squamous cell carcinoma of the penis successfully treated with imiquimod 5% cream in a porphyria cutanea tarda patient.
    Dermatologic therapy, 2017, Volume: 30, Issue:3

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Porphyria Cutanea Tarda; Treatment Outcome

2017
Pseudocarcinomatous Epithelial Hyperplasia Induced by Imiquimod: A Mimic of Cutaneous Squamous Cell Carcinoma.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2017, Volume: 43, Issue:6

    Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma in Situ; Carcinoma, Squamous Cell; Diagnosis, Differential; Facial Dermatoses; Female; Forehead; Humans; Hyperplasia; Imiquimod

2017
Definitive surgical treatment of 24 skin cancers not cured by prior imiquimod therapy: a case series.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2008, Volume: 34, Issue:9

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Male; Melanoma; Middle Aged; Mohs Surgery; Skin Neoplasms; Treatment Outcome

2008
Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.
    Clinical therapeutics, 2008, Volume: 30, Issue:7

    Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Hydroxyurea; Hyperpigmentation; Imiquimod; Male; Myeloproliferative Disorders; Nail Diseases; Skin Neoplasms

2008
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells.
    The Journal of experimental medicine, 2008, Sep-29, Volume: 205, Issue:10

    Topics: Aminoquinolines; Antigens, CD; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Movement; Down-Regulation; E-Selectin; Endothelial Cells; Forkhead Transcription Factors; Humans; Imiquimod; Immune System; Immunologic Memory; Interleukin-10; Interleukin-6; Lymphocyte Activation; Nitric Oxide Synthase Type II; Skin; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Tumor Escape

2008
Eruptive keratoacanthoma following topical imiquimod for in situ squamous cell carcinoma of the skin in a renal transplant recipient.
    Journal of the American Academy of Dermatology, 2008, Volume: 59, Issue:5 Suppl

    Topics: Aged, 80 and over; Aminoquinolines; Bowen's Disease; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratosis, Actinic; Kidney Transplantation; Skin Neoplasms

2008
Coexisting perianal squamous cell carcinoma, Bowen's disease, and condylomata acuminata treated with topical imiquimod 5%.
    International journal of dermatology, 2008, Volume: 47, Issue:12

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Anus Diseases; Anus Neoplasms; Bowen's Disease; Carcinoma, Squamous Cell; Condylomata Acuminata; Female; Humans; Imiquimod; Immunologic Factors; Middle Aged; Neoplasms, Multiple Primary; Skin Neoplasms

2008
Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005).
    Veterinary and comparative oncology, 2008, Volume: 6, Issue:1

    Topics: Aminoquinolines; Animals; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Cat Diseases; Cats; Female; Imiquimod; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome

2008
Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.
    The Journal of investigative dermatology, 2009, Volume: 129, Issue:11

    Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Biopsy; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cell Division; Granzymes; Humans; Imiquimod; In Vitro Techniques; Interferon-gamma; Interleukin-10; Lymphocyte Activation; Perforin; Pore Forming Cytotoxic Proteins; Signal Transduction; Skin Neoplasms; Transforming Growth Factor beta

2009
A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
    Journal of the American Academy of Dermatology, 2009, Volume: 61, Issue:1

    Topics: Ambulatory Surgical Procedures; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cheek; Cost-Benefit Analysis; Curettage; Frozen Sections; Humans; Imiquimod; Mohs Surgery; Plastic Surgery Procedures; Skin Neoplasms

2009
Bone invasion by squamous cell carcinoma in situ (Bowen's disease) of the finger during treatment with imiquimod 5% cream: case report.
    The Journal of hand surgery, 2010, Volume: 35, Issue:6

    Topics: Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Finger Joint; Fingers; Humans; Imiquimod; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Radiography; Skin Neoplasms

2010
The use of imiquimod in the treatment of periocular tumours.
    Orbit (Amsterdam, Netherlands), 2010, Volume: 29, Issue:2

    Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Eyelid Neoplasms; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Skin Neoplasms; Treatment Outcome

2010
Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms.
    Cutis, 2010, Volume: 85, Issue:4

    Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Arsenic; Carcinoma, Squamous Cell; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Neoplasm Recurrence, Local; Psoriasis; Skin Neoplasms

2010
Current management of actinic keratoses.
    Skin therapy letter, 2010, Volume: 15, Issue:5

    Topics: Administration, Cutaneous; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Squamous Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms

2010
Detection and treatment of preclinical actinic keratoses (PAK).
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2010, Volume: 8, Issue:9

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Facial Dermatoses; Female; Humans; Imiquimod; Keratosis, Actinic; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Skin Aging

2010
The efficacy of imiquimod on dysplastic lesions of the oral mucosa: an experimental model.
    Anticancer research, 2010, Volume: 30, Issue:7

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Antineoplastic Agents; Carcinogens; Carcinoma, Squamous Cell; Imiquimod; Male; Mouth Mucosa; Mouth Neoplasms; Precancerous Conditions; Rats; Rats, Wistar

2010
Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:10

    Topics: Algorithms; Aminoquinolines; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryosurgery; Curettage; Dermatology; Diagnosis, Differential; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Mohs Surgery; Photochemotherapy; Precancerous Conditions; Reproducibility of Results; Skin Neoplasms; Terminology as Topic; United States

2010
Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin.
    The Australasian journal of dermatology, 2011, Volume: 52, Issue:1

    Topics: Acitretin; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratolytic Agents; Skin Neoplasms; Treatment Outcome

2011
What's new in the treatment of actinic keratoses?
    Cutis, 2011, Volume: 87, Issue:2

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Diterpenes; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms

2011
Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin.
    The Journal of dermatology, 2011, Volume: 38, Issue:4

    Topics: Acitretin; Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratolytic Agents; Skin Neoplasms

2011
Modulation of the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: novel therapies for squamous cell carcinoma of the head and neck.
    Head & neck, 2012, Volume: 34, Issue:4

    Topics: Aminoquinolines; Analysis of Variance; Animals; Carcinoma, Squamous Cell; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Drug Administration Schedule; Head and Neck Neoplasms; Humans; Imiquimod; Injections, Intraperitoneal; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Receptors, Opioid; Reference Values; Squamous Cell Carcinoma of Head and Neck; Transplantation, Heterologous; Treatment Outcome; Tumor Burden; Up-Regulation

2012
Cryoimmunotherapy: superficial basal cell cancer and squamous cell carcinoma in situ treated with liquid nitrogen followed by imiquimod.
    Archives of dermatology, 2011, Volume: 147, Issue:11

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cryotherapy; Female; Follow-Up Studies; Humans; Imiquimod; Immunotherapy; Male; Nitrogen; Retrospective Studies; Skin Neoplasms

2011
Persistent erythematous lesion of the vulva: a diagnostic and treatment challenge.
    Journal of drugs in dermatology : JDD, 2012, Volume: 11, Issue:1

    Topics: Administration, Topical; Aminoquinolines; Bowen's Disease; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; Treatment Outcome; Vulva

2012
Solar cheilosis: an ominous precursor part II. Therapeutic perspectives.
    Journal of the American Academy of Dermatology, 2012, Volume: 66, Issue:2

    Topics: Administration, Topical; Aminoquinolines; Biopsy; Carcinoma, Squamous Cell; Cheilitis; Combined Modality Therapy; Diagnosis, Differential; Diclofenac; Female; Fluorouracil; Humans; Imiquimod; Lip Neoplasms; Male; Middle Aged; Precancerous Conditions; Skin Neoplasms; Sunlight

2012
Imiquimod attenuates the growth of UVB-induced SCC in mice through Th1/Th17 cells.
    Molecular carcinogenesis, 2013, Volume: 52, Issue:10

    Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cell Transformation, Neoplastic; Cytokines; Dendritic Cells; Epidermis; Imiquimod; Immunoenzyme Techniques; Keratinocytes; Mice; Mice, Transgenic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; STAT3 Transcription Factor; Th1 Cells; Th17 Cells; Ultraviolet Rays

2013
Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2012, Volume: 41, Issue:7

    Topics: Aminoquinolines; Analysis of Variance; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Proliferation; Humans; Imiquimod; Mouth Neoplasms; Necrosis; Toll-Like Receptor 7; Tumor Cells, Cultured

2012
Human papillomavirus type 73 associated with multiple cutaneous squamous cell carcinomas in an immunosuppressed patient.
    International journal of dermatology, 2012, Volume: 51, Issue:6

    Topics: Adult; Aminoquinolines; Amputation, Surgical; Antineoplastic Agents; Carcinoma, Squamous Cell; DNA, Viral; Fingers; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Lip Neoplasms; Male; Mohs Surgery; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Skin Neoplasms

2012
Effects of imiquimod and low-intensity laser (λ660 nm) in chemically induced oral carcinomas in hamster buccal pouch mucosa.
    Lasers in medical science, 2013, Volume: 28, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cheek; Combined Modality Therapy; Cricetinae; Imiquimod; Low-Level Light Therapy; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms

2013
[Item 149--Epithelial and melanotic skin tumors: human papillomavirus (HPV) tumors].
    Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:11 Suppl

    Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Combined Modality Therapy; Condylomata Acuminata; Cryosurgery; Cryotherapy; Female; Gammapapillomavirus; Humans; Imiquimod; Immunocompromised Host; Laser Therapy; Lasers, Gas; Male; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Neoplastic; Risk; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaccination; Warts

2012
Arbor cutis: hyperkeratotic plaque secondary to the use of imiquimod for the treatment of squamous cell carcinoma in situ.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:4

    Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Eruptions; Female; Forearm; Humans; Imiquimod; Keratosis; Skin Neoplasms

2013
Treatment of squamous cell carcinoma in situ of the penis with 5% imiquimod cream: a case report.
    Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:4 Suppl

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Interferon Inducers; Male; Penile Neoplasms

2002
Catching skin cancer early. New treatments aim to keep keratoses from developing into invasive cancer.
    Health news (Waltham, Mass.), 2002, Volume: 8, Issue:12

    Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Humans; Imiquimod; Keratosis; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms

2002
Malignant conversion of florid oral and labial papillomatosis during topical immunotherapy with imiquimod.
    Medical microbiology and immunology, 2003, Volume: 192, Issue:3

    Topics: Aminoquinolines; Carcinoma, Squamous Cell; Electrosurgery; Female; Humans; Imiquimod; Laser Therapy; Lip Neoplasms; Middle Aged; Mouth Neoplasms; Papilloma

2003
Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect.
    European journal of obstetrics, gynecology, and reproductive biology, 2003, Aug-15, Volume: 109, Issue:2

    Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Pemphigus; Treatment Outcome; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Diseases; Vulvar Neoplasms

2003
New and emerging treatments for nonmelanomas and actinic keratoses.
    Journal of drugs in dermatology : JDD, 2003, Volume: 2, Issue:4

    Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diclofenac; Humans; Imiquimod; Keratosis; Photochemotherapy; Skin Neoplasms

2003
Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod.
    Journal of the National Cancer Institute, 2003, Aug-06, Volume: 95, Issue:15

    Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cytochrome c Group; DNA Fragmentation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Imiquimod; Immunologic Factors; In Situ Nick-End Labeling; Keratinocytes; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor; Tumor Cells, Cultured; Up-Regulation

2003
Treatment of Bowen's disease of the penis with imiquimod 5% cream.
    Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Emollients; Humans; Imiquimod; Male; Middle Aged; Ointments; Penile Neoplasms; Treatment Outcome

2003
Treatment of Bowen's disease using a cycle regimen of imiquimod 5% cream.
    Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1

    Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Ointments; Skin Neoplasms; Treatment Outcome

2003
Treatment of large facial Bowen's disease: case report.
    Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1

    Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Facial Neoplasms; Female; Humans; Imiquimod; Ointments; Treatment Outcome

2003
[Cutaneous epithelial tumors. Molecular biology and pathogenesis-based therapy].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:12

    Topics: Adjuvants, Immunologic; Alleles; Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cerebellar Neoplasms; Disease Models, Animal; Genes, Tumor Suppressor; Hedgehog Proteins; Humans; Imiquimod; Medulloblastoma; Membrane Proteins; Mice; Mutation; Patched Receptors; Patched-1 Receptor; Receptors, Cell Surface; Signal Transduction; Skin Neoplasms; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Veratrum Alkaloids

2003
Two cases of squamous cell carcinoma treated with topical imiquimod 5%.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2004, Volume: 18, Issue:1

    Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Skin Neoplasms

2004
Successful treatment of invasive squamous cell carcinoma using topical imiquimod.
    Archives of dermatology, 2004, Volume: 140, Issue:4

    Topics: Administration, Topical; Aged; Aminoquinolines; Biopsy, Needle; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Face; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Neoplasm Invasiveness; Risk Assessment; Skin Neoplasms; Treatment Outcome

2004
Invasive squamous cell carcinoma treated with imiquimod 5% cream.
    Acta dermato-venereologica, 2004, Volume: 84, Issue:3

    Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Imiquimod; Leg; Male; Neoplasm Invasiveness; Ointments; Skin Neoplasms; Treatment Outcome

2004
Localized pemphigus foliaceus induced by topical imiquimod treatment.
    Archives of dermatology, 2004, Volume: 140, Issue:7

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diagnosis, Differential; Drug Eruptions; Face; Facial Dermatoses; Female; Humans; Imiquimod; Middle Aged; Pemphigus; Skin Neoplasms

2004
Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern.
    Clinical and experimental dermatology, 2004, Volume: 29, Issue:5

    Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cytokines; Female; Humans; Imiquimod; Immunohistochemistry; Leukocytes, Mononuclear; Macrophages; Male; Middle Aged; Skin Neoplasms

2004
Infiltrative squamous cell carcinoma on the scalp after treatment with 5% imiquimod cream.
    Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:4

    Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma, Squamous Cell; Dosage Forms; Head and Neck Neoplasms; Humans; Imiquimod; Male; Scalp; Skin Neoplasms

2005
Imiquimod: an effective alternative for the treatment of invasive cutaneous squamous cell carcinoma.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005, Volume: 31, Issue:3

    Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratinocytes; Male; Skin Neoplasms

2005
Imiquimod 5% cream: a new treatment for Bowen's disease.
    International journal of tissue reactions, 2005, Volume: 27, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Biopsy; Bowen's Disease; Carcinoma, Squamous Cell; Epidermis; Female; Humans; Imiquimod; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms; Time Factors; Treatment Outcome

2005
Imiquimod and squamous cell cancer.
    Archives of dermatology, 2005, Volume: 141, Issue:6

    Topics: Aminoquinolines; Biopsy, Needle; Bowen's Disease; Carcinoma, Squamous Cell; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Precancerous Conditions; Risk Assessment; Skin Neoplasms; Treatment Outcome

2005
Imiquimod to treat basal cell and squamous cell carcinomas.
    American family physician, 2005, Jul-01, Volume: 72, Issue:1

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Drug Approval; Humans; Imiquimod; Patient Selection; Skin Neoplasms; United States; United States Food and Drug Administration

2005
Successful treatment of penile Bowen's disease with 5% imiquimod cream.
    International journal of STD & AIDS, 2005, Volume: 16, Issue:9

    Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Penile Diseases; Skin Neoplasms; Treatment Outcome

2005
Therapy of cutaneous squamous cell carcinoma in two retirement home residents.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005, Volume: 3, Issue:9

    Topics: Adjuvants, Immunologic; Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Hand Dermatoses; Homes for the Aged; Humans; Imiquimod; Skin Neoplasms; Surgical Flaps; Treatment Outcome

2005
Aggressive undifferentiated squamous cell carcinoma in an immunosuppressed patient after kidney transplantation.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005, Volume: 3, Issue:1

    Topics: Acitretin; Adjuvants, Immunologic; Administration, Oral; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Counseling; Cyclosporine; Follow-Up Studies; Humans; Imiquimod; Immunocompromised Host; Immunosuppressive Agents; Keratolytic Agents; Keratosis; Kidney Transplantation; Male; Middle Aged; Ointments; Skin; Skin Neoplasms; Sunscreening Agents; Time Factors

2005
Treatment of multiple lesions of Bowen's disease and squamous cell carcinoma with topical imiquimod.
    The Journal of dermatology, 2005, Volume: 32, Issue:12

    Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Bowen's Disease; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Neoplasm Staging; Risk Assessment; Skin Neoplasms; Treatment Outcome

2005
Treatment of invasive squamous cell carcinoma with 5-percent imiquimod cream.
    Dermatology online journal, 2006, Mar-30, Volume: 12, Issue:3

    Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Neoplasm Invasiveness; Ointments; Skin Neoplasms; Treatment Outcome

2006
Apoptotic responses in squamous carcinoma and epithelial cells to small-molecule toll-like receptor agonists evaluated with automated cytometry.
    Journal of biomolecular screening, 2006, Volume: 11, Issue:6

    Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Automation; Carcinoma, Squamous Cell; Cell Line; Cytological Techniques; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Imiquimod; Keratinocytes; Toll-Like Receptors

2006
A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: a therapeutic challenge.
    The Journal of dermatological treatment, 2006, Volume: 17, Issue:3

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Diagnosis, Differential; Drug Therapy, Combination; Epidermodysplasia Verruciformis; Humans; Imiquimod; Interferons; Male; Middle Aged; Scalp; Skin Neoplasms

2006
Invasive squamous cell carcinoma after treatment of carcinoma in situ with 5% imiquimod cream.
    The Australasian journal of dermatology, 2006, Volume: 47, Issue:3

    Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Head and Neck Neoplasms; Humans; Imiquimod; Leg; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Second Primary; Scalp; Skin Neoplasms; Treatment Outcome

2006
Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratoses.
    Acta dermato-venereologica, 2006, Volume: 86, Issue:4

    Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Squamous Cell; Humans; Imiquimod; Keratoacanthoma; Keratosis; Male; Middle Aged; Skin Neoplasms; Ultraviolet Rays

2006
Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6

    Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Squamous Cell; Cytokines; Drug Evaluation; Drug Synergism; Fingers; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Ointments; Prodrugs; Remission Induction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8

2006
Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.
    Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:5

    Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Epidermodysplasia Verruciformis; Humans; Imiquimod; Male; Membrane Proteins; Mutation; Skin Neoplasms

2007
Treating actinic keratoses with imiquimod.
    Australian family physician, 2007, Volume: 36, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Squamous Cell; Cryotherapy; Facial Dermatoses; Humans; Imiquimod; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Scalp Dermatoses; Skin Neoplasms

2007
Conservative management of recurrent nasal squamous papilloma with topical immunomodulators.
    Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2007, Volume: 32, Issue:3

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Squamous Cell; Humans; Imiquimod; Nose Neoplasms; Papilloma

2007
Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Cutis, 2007, Volume: 79, Issue:3

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Curettage; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome

2007
Squamous cell carcinoma on the scalp following treatment with 5% imiquimod cream.
    Clinical and experimental dermatology, 2007, Volume: 32, Issue:5

    Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Imiquimod; Keratosis; Male; Radiodermatitis; Scalp; Skin Neoplasms

2007
Apparent clinical resolution of pinnal actinic keratoses and squamous cell carcinoma in a cat using topical imiquimod 5% cream.
    Journal of feline medicine and surgery, 2008, Volume: 10, Issue:6

    Topics: Aminoquinolines; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cat Diseases; Cats; Ear Auricle; Female; Imiquimod; Skin Neoplasms; Treatment Outcome

2008
Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function.
    Experimental biology and medicine (Maywood, N.J.), 2008, Volume: 233, Issue:8

    Topics: Adenocarcinoma; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Head and Neck Neoplasms; Humans; Imiquimod; Immunity; Narcotic Antagonists; Pancreatic Neoplasms; Receptors, Opioid; RNA, Small Interfering; Up-Regulation

2008
Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy.
    Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Skin Neoplasms

2008
Bowen's disease of the penis treated with topical imiquimod 5% cream.
    Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Ointments; Penile Neoplasms; Skin Neoplasms

2008
Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man.
    Archives of dermatology, 2001, Volume: 137, Issue:1

    Topics: Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Drug Administration Schedule; Fluorouracil; HIV Infections; HIV-1; Humans; Imiquimod; Male; Middle Aged

2001
Topical imiquimod to treat intraepidermal carcinoma.
    Archives of dermatology, 2001, Volume: 137, Issue:6

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Nose; Photosensitivity Disorders; Precancerous Conditions; Skin Neoplasms; Thorax

2001
Successful topical immunotherapy of bowenoid papulosis with imiquimod.
    The British journal of dermatology, 2001, Volume: 145, Issue:6

    Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Interferon Inducers; Vulvar Neoplasms

2001
Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream.
    Journal of the American Academy of Dermatology, 2002, Volume: 46, Issue:4

    Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Humans; Imiquimod; Male; Ointments; Penile Neoplasms; Skin Neoplasms

2002